KPIs & Operating Metrics(New)
Growth Metrics

Tenet Healthcare (THC) Equity Income (2016 - 2026)

Tenet Healthcare (THC) has disclosed Equity Income for 13 consecutive years, with $51.0 million as the latest value for Q1 2026.

  • For Q1 2026, Equity Income fell 8.93% year-over-year to $51.0 million; the TTM value through Mar 2026 reached $259.0 million, up 0.78%, while the annual FY2025 figure was $264.0 million, 1.54% up from the prior year.
  • Equity Income hit $51.0 million in Q1 2026 for Tenet Healthcare, down from $83.0 million in the prior quarter.
  • Across five years, Equity Income topped out at $83.0 million in Q4 2025 and bottomed at $46.0 million in Q1 2022.
  • Average Equity Income over 5 years is $59.9 million, with a median of $59.0 million recorded in 2024.
  • Year-over-year, Equity Income dropped 15.58% in 2022 and then grew 21.57% in 2024.
  • Tenet Healthcare's Equity Income stood at $65.0 million in 2022, then grew by 12.31% to $73.0 million in 2023, then increased by 6.85% to $78.0 million in 2024, then increased by 6.41% to $83.0 million in 2025, then crashed by 38.55% to $51.0 million in 2026.
  • According to Business Quant data, Equity Income over the past three periods came in at $51.0 million, $83.0 million, and $64.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.